Health Canada
- Status: approved
bOPV and IPV and IPV2 (bOPV and IPV and IPV2) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Aga Khan University is the originator. The local marketing authorisation holder may differ — check the official source linked above.